Japanese Encephalitis Vaccines Market size to grow by USD 58.27 million from 2021 to 2026, Driven by inclusion in the national immunization plan - Technavio

NEW YORK, April 4, 2023 /PRNewswire/ -- The Japanese encephalitis vaccine market size is estimated to increase by USD 58.27 million from 2021 to 2026. The market growth will progress at a CAGR of 5.98% during the forecast period, according to a recent market study by Technavio. A key factor fueling the Japanese encephalitis vaccine market growth is the inclusion in the national immunization plan. The growing number of indications caused by deadly viruses has encouraged governments to come up with national immunization plans. For instance, in 1978, the Ministry of Health and Family Welfare, Government of India, introduced the Expanded Programme of Immunization, which was changed to the Universal Immunization Programme in 1985. This program aims to ensure that the population in the affected parts of the country is immunized against infectious diseases. Asian countries such as Thailand, Malaysia, and the Philippines also contribute to the increasing demand for Japanese encephalitis vaccines, which, in turn, will fuel market growth in the forecast years. Discover some insights on market size before buying the full report - Request a sample report
Japanese Encephalitis Vaccines Market - Segmentation Analysis

The Japanese encephalitis vaccines market research report extensively covers market segmentation by type (inactivated vaccines, recombinant vaccines, and live attenuated vaccines) and geography (Asia, ROW, Europe, and North America).

• The market share growth by the inactivated vaccines will be significant during the forecast period. Formaldehyde or formalin is the most commonly used chemical to inactivate a pathogen. When exposed to these chemicals, the pathogen loses its ability to replicate. Thus, it does not cause any harm to the body. The pathogen is either kept intact or is left with some of its integrity to ensure that the immune system recognizes it and starts an immune response. The need for booster injections for inactivated vaccines is expected to help the segment grow in terms of both volume and value during the forecast period. 

Geographic Analysis

• Asia is estimated to account for 72% of the market growth during the forecast period. China, India, Japan, and South Korea are the key markets for Japanese encephalitis vaccines in the region. Market growth in this region will be faster than the growth of the market in other regions. The growth in Asia can be attributed to factors such as the increased risk of the indication in over three billion people in the region. Due to the unavailability of a cure for the disease, various vendors such as Sanofi, Valneva, and Bharat Biotech and organizations such as UNICEF, WHO, and Gavi are focusing on preventing the disease by using vaccines. Hence, the risk of indication will lead to the growth of the Japanese encephalitis market in the region during the forecast period.

Insights on the market contribution of various segments, including country- and region-wise data and forecast market size (2021 to 2026) - Download a Sample Report

Why buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio - buy the report!

Japanese Encephalitis Vaccines Market - Vendor Analysis

The global Japanese encephalitis vaccines market is a highly regulated market with a limited number of vendors. These vendors manufacture the vaccines and largely supply them to organizations such as the WHO, UNICEF, and Gavi, which distribute them in affected countries. Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc., Panacea Biotec Ltd., Sanofi, Shandong Hengye Biotechnology Co. Ltd., and Valneva SE are some of the major vendors in the market.

Japanese Encephalitis Vaccines Market - Market Analysis

Emerging Trends

• One of the key Japanese encephalitis vaccine market trends is the novel vaccine technology.
• Different types of vaccines are available for the prevention of the indication, but the market still witnesses an unmet need for highly effective vaccines for the prevention of the indication.
• Researchers conduct studies on microribonucleic acid (microRNA) as a potential therapeutic candidate for Japanese encephalitis.
• Studies show that microRNA-155 can regulate the inflammatory response caused by the Japanese encephalitis virus, and investment in R&D is expected to further support the market growth during the forecast period.

Major Challenges

• Demand-supply imbalance is a key challenge hindering the Japanese encephalitis vaccine market growth.
• Most cases of Japanese encephalitis are seasonal, which means various manufacturers tend to manufacture the vaccines in large quantities and store them.
• Despite being produced in large quantities, the vaccine faces the risk of low shelf life, as most of these vaccines have a shelf life of fewer than two years on average.
• The market faces issues with storage, as these vaccines are required to be stored in cold chain storage, which is very expensive. As a result, small and mid-sized vendors can manufacture the vaccines only when the demand is high in the market.
• Japanese encephalitis vaccines also take a long time to manufacture and deliver to the required region, which creates a gap between the demand and the supply in the market.

Insights on Market Drivers, trends, & Challenges and forecast period (2021 to 2026) - Request a sample report!

What are the key data covered in this Japanese Encephalitis Vaccines Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the Japanese encephalitis vaccines market between 2022 and 2026
• Precise estimation of the size of the Japanese encephalitis vaccines market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the apanese encephalitis vaccines market across Asia, Rest of World (ROW), Europe, and North America
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of Japanese encephalitis vaccines market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The mycosis fungoides therapeutics market size has the potential to grow by USD 115.42 million during 2020-2025, and the market's growth momentum will accelerate at a CAGR of 4.90%. This report provides a detailed analysis of the market by type (small molecules and biologics), geography (North America, Europe, Asia, and ROW), and key vendors. 

The laryngeal cancer therapeutics market size is expected to increase by USD 635.07 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7%. The report extensively covers laryngeal cancer therapeutics market segmentation by type (biologics and small molecules) and geography (North America, Europe, Asia, and ROW). A key factor driving growth in the laryngeal cancer therapeutics market is the increasing prevalence of laryngeal cancer. 

Browse for Technavio's Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type

• 5.3 Inactivated vaccines - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Inactivated vaccines - Year-over-year growth 2021-2026 (%)

• 5.4 Recombinant vaccines - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Recombinant vaccines - Year-over-year growth 2021-2026 (%)

• 5.5 Live attenuated vaccines - Market size and forecast 2021-2026 
• Exhibit 36: Chart on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Type 
• Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 Asia - Market size and forecast 2021-2026 
• Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.4 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 50: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.5 Europe - Market size and forecast 2021-2026 
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.6 North America - Market size and forecast 2021-2026 
• Exhibit 58: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.7 China - Market size and forecast 2021-2026 
• Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.8 India - Market size and forecast 2021-2026 
• Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)

• 7.9 Japan - Market size and forecast 2021-2026 
• Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.10 Republic of Korea - Market size and forecast 2021-2026 
• Exhibit 74: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)

• 7.11 Australia - Market size and forecast 2021-2026 
• Exhibit 78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Australia - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Australia - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 88: Matrix on vendor position and classification

• 10.3 Adimmune Corp.
• Exhibit 89: Adimmune Corp. - Overview
• Exhibit 90: Adimmune Corp. - Business segments
• Exhibit 91: Adimmune Corp. - Key news
• Exhibit 92: Adimmune Corp. - Key offerings
• Exhibit 93: Adimmune Corp. - Segment focus

• 10.4 Bharat Biotech Ltd.
• Exhibit 94: Bharat Biotech Ltd. - Overview
• Exhibit 95: Bharat Biotech Ltd. - Product / Service
• Exhibit 96: Bharat Biotech Ltd. - Key news
• Exhibit 97: Bharat Biotech Ltd. - Key offerings

• 10.5 Biological E. Ltd.
• Exhibit 98: Biological E. Ltd. - Overview
• Exhibit 99: Biological E. Ltd. - Product / Service
• Exhibit 100: Biological E. Ltd. - Key news
• Exhibit 101: Biological E. Ltd. - Key offerings

• 10.6 KM Biologics Co. Ltd. 
• Exhibit 102: KM Biologics Co. Ltd. - Overview
• Exhibit 103: KM Biologics Co. Ltd. - Product / Service
• Exhibit 104: KM Biologics Co. Ltd. - Key offerings

• 10.7 Medigen Inc.
• Exhibit 105: Medigen Inc. - Overview
• Exhibit 106: Medigen Inc. - Product / Service
• Exhibit 107: Medigen Inc. - Key offerings

• 10.8 Panacea Biotec Ltd.
• Exhibit 108: Panacea Biotec Ltd. - Overview
• Exhibit 109: Panacea Biotec Ltd. - Product / Service
• Exhibit 110: Panacea Biotec Ltd. - Key offerings

• 10.9 Sanofi
• Exhibit 111: Sanofi - Overview
• Exhibit 112: Sanofi - Business segments
• Exhibit 113: Sanofi - Key news
• Exhibit 114: Sanofi - Key offerings
• Exhibit 115: Sanofi - Segment focus

• 10.10 Shandong Hengye Biotechnology Co. Ltd. 
• Exhibit 116: Shandong Hengye Biotechnology Co. Ltd. - Overview
• Exhibit 117: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
• Exhibit 118: Shandong Hengye Biotechnology Co. Ltd. - Key offerings

• 10.11 Valneva SE
• Exhibit 119: Valneva SE - Overview
• Exhibit 120: Valneva SE - Business segments
• Exhibit 121: Valneva SE - Key offerings
• Exhibit 122: Valneva SE - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 123: Inclusions checklist
• Exhibit 124: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 125: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 126: Research methodology
• Exhibit 127: Validation techniques employed for market sizing
• Exhibit 128: Information sources

• 11.5 List of abbreviations 
• Exhibit 129: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio